Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeximod in Moderate COVID-19 (Randomized, Placebo-Controlled, Double-Blind Phase 2 Study)
2020-004571-41Phase 2Completed
- Sponsor
- Cyxone
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Rabeximod + standard of care with Placebo + standard of care (2 arms). Started Nov 2020; status: completed.
02
Drugs
rabeximod
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-004571-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004571-41.